Showing results (1-10 of 411) with videos related to
Sort By:
Pageof 42
Chest|August 1, 1993
Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosisA Pollak, R H FalkAmerican Heart Journal|March 1, 1993
Pacemaker therapy in patients with atrial fibrillationA Pollak, R H FalkJournal of the American College of Cardiology|March 1, 1995
Aggravation of postcardioversion atrial dysfunction by sotalolA Pollak, R H FalkBritish Heart Journal|November 1, 1995
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociationS Dubrey, A Pollak, M Skinner, et al.The American Journal of Cardiology|September 12, 2000
Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutterJ M DeCara, A Pollak, S Dubrey, et al.Journal of the American College of Cardiology|February 1, 1997
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide InvestigatorsR H Falk, A Pollak, S N Singh, et al.Cardiology Clinics|November 1, 1996
Pharmacologic control of heart rate in atrial fibrillationR H FalkJournal of the American College of Cardiology|April 1, 1990
Impact of prospective peer review on pacemaker implantation rates in MassachusettsR H FalkThe American Journal of Cardiology|November 11, 1998
Etiology and complications of atrial fibrillation: insights from pathology studiesR H FalkClinical Cardiology|April 17, 2001
The cardiovascular response to sexual activity: do we know enough?R H FalkPageof 42